Search research articles
Contact Us
Filters
Showing results (91-100 of 117) with videos related to
Page
of 12
Sort By:
Neuro-Oncology Advances
|
February 8, 2023
Tandem chimeric antigen receptor (CAR) T cells targeting EGFRvIII and IL-13Rα2 are effective against heterogeneous glioblastoma
Andrea Schmidts, Ambike A Srivastava, Rishab Ramapriyan, et al.
Neuro-Oncology
|
December 15, 2025
Tumor-Infiltrating Lymphocyte Therapy Generated from Melanoma Brain Metastasis: Proof-of-Concept for CNS-Derived Cellular Immunotherapy
Eric P Grewal, Samuel J Steuart, Baolin Liu, et al.
Nature Medicine
|
September 13, 2022
Distinct cellular dynamics associated with response to CAR-T therapy for refractory B cell lymphoma
Nicholas J Haradhvala, Mark B Leick, Katie Maurer, et al.
Journal of the American College of Cardiology
|
December 21, 2019
Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T)
Raza M Alvi, Matthew J Frigault, Michael G Fradley, et al.
Journal for Immunotherapy of Cancer
|
January 28, 2022
Phase I clinical trial evaluating the safety and efficacy of ADP-A2M10 SPEAR T cells in patients with MAGE-A10<sup>+</sup> advanced non-small cell lung cancer
George R Blumenschein, Siddhartha Devarakonda, Melissa Johnson, et al.
Blood
|
March 3, 2026
Real-world outcomes for lisocabtagene maraleucel in patients with relapsed or refractory large B-cell lymphoma
Jennifer L Crombie, Sairah Ahmed, Matthew J Frigault, et al.
Lancet (London, England)
|
December 14, 2020
Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studies
Reuben Benjamin, Charlotte Graham, Deborah Yallop, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 16, 2020
Axicabtagene Ciloleucel in the Non-Trial Setting: Outcomes and Correlates of Response, Resistance, and Toxicity
Caron A Jacobson, Bradley D Hunter, Robert Redd, et al.
Blood Advances
|
March 12, 2024
Third-party fecal microbiota transplantation for high-risk treatment-naïve acute GVHD of the lower GI tract
Zachariah DeFilipp, Ashish V Damania, Haesook T Kim, et al.
Blood
|
February 15, 2022
Safety and efficacy of tisagenlecleucel in primary CNS lymphoma: a phase 1/2 clinical trial
Matthew J Frigault, Jorg Dietrich, Kathleen Gallagher, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 117) with videos related to
Sort By:
Page
of 12
Neuro-Oncology Advances
|
February 8, 2023
Tandem chimeric antigen receptor (CAR) T cells targeting EGFRvIII and IL-13Rα2 are effective against heterogeneous glioblastoma
Andrea Schmidts, Ambike A Srivastava, Rishab Ramapriyan, et al.
Neuro-Oncology
|
December 15, 2025
Tumor-Infiltrating Lymphocyte Therapy Generated from Melanoma Brain Metastasis: Proof-of-Concept for CNS-Derived Cellular Immunotherapy
Eric P Grewal, Samuel J Steuart, Baolin Liu, et al.
Nature Medicine
|
September 13, 2022
Distinct cellular dynamics associated with response to CAR-T therapy for refractory B cell lymphoma
Nicholas J Haradhvala, Mark B Leick, Katie Maurer, et al.
Journal of the American College of Cardiology
|
December 21, 2019
Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T)
Raza M Alvi, Matthew J Frigault, Michael G Fradley, et al.
Journal for Immunotherapy of Cancer
|
January 28, 2022
Phase I clinical trial evaluating the safety and efficacy of ADP-A2M10 SPEAR T cells in patients with MAGE-A10<sup>+</sup> advanced non-small cell lung cancer
George R Blumenschein, Siddhartha Devarakonda, Melissa Johnson, et al.
Blood
|
March 3, 2026
Real-world outcomes for lisocabtagene maraleucel in patients with relapsed or refractory large B-cell lymphoma
Jennifer L Crombie, Sairah Ahmed, Matthew J Frigault, et al.
Lancet (London, England)
|
December 14, 2020
Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studies
Reuben Benjamin, Charlotte Graham, Deborah Yallop, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 16, 2020
Axicabtagene Ciloleucel in the Non-Trial Setting: Outcomes and Correlates of Response, Resistance, and Toxicity
Caron A Jacobson, Bradley D Hunter, Robert Redd, et al.
Blood Advances
|
March 12, 2024
Third-party fecal microbiota transplantation for high-risk treatment-naïve acute GVHD of the lower GI tract
Zachariah DeFilipp, Ashish V Damania, Haesook T Kim, et al.
Blood
|
February 15, 2022
Safety and efficacy of tisagenlecleucel in primary CNS lymphoma: a phase 1/2 clinical trial
Matthew J Frigault, Jorg Dietrich, Kathleen Gallagher, et al.
Page
of 12